tirzepatide and wegovy (Semaglutide) vs Mounjaro (Tirzepatide) Tirzepatide vs Semaglutide for Weight

In the tirzepatide trial, participants lost an average of 6.9% of their weight after 12 weeks, while retatrutide participants lost 7.2% at the lowest dose after 24 weeks

The situation remains fluid

Inject Mounjaro subcutaneously (under the skin) in your stomach (abdomen), thigh, or upper arm

The ritual becomes automatic

But they can fail to find what symptoms patients are most concerned about

See: FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss In general, patients should be extremely cautious, always consult their care provider, and thoroughly vet any pharmacy they consider for compounded medications